3-D Matrix Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Public

  • Employees
  • 129

Employees

  • Stock Symbol
  • 7777

Stock Symbol

  • Investments
  • 2

  • Share Price
  • $1.89
  • (As of Tuesday Closing)

3-D Matrix General Information

Description

3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Additionally, the company develops ready-to-use hemostatic gels, mucosal elevation agents, and sealants to manage bleeding during complex procedures in gastroenterology, cardiac surgery, ENT, and urology. Its product portfolio includes PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • 3-2-4 Kojimachi, Chiyoda-ku
  • 7th floor, Kojimachi HF Building
  • Tokyo, 102-0083
  • Japan
+81
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Stock Exchange
TKS
Corporate Office
  • 3-2-4 Kojimachi, Chiyoda-ku
  • 7th floor, Kojimachi HF Building
  • Tokyo, 102-0083
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

3-D Matrix Stock Performance

As of 17-Nov-2026, 3-D Matrix’s stock price is $1.89. Its current market cap is $241M with 128M shares.

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.89 $1.93 $1.79 - $5.01 $241M 128M 2.14M $0.20

3-D Matrix Financials Summary

As of 31-Jul-2026, 3-D Matrix has a trailing 12-month revenue of $76.5M.

In Thousands,
USD
TTM 31-Jul-2026 FY 2026 30-Apr-2026 FY 2025 30-Apr-2025 FY 2024 30-Apr-2024
EV 248,907 377,707 104,712 79,457
Revenue 76,517 71,645 45,704 31,395
EBITDA 27,428
Net Income 23,714 27,350 (16,486) (1,748)
Total Assets 58,687 61,150 45,759 37,653
Total Debt 3,745 3,746 20,660 26,699
Public Fundamental Data provided by Morningstar, Inc. disclaimer

3-D Matrix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore 3-D Matrix‘s full profile, request access.

Request a free trial

3-D Matrix Patents

3-D Matrix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026064790-A1 Novel peptide compositions and their use for the treatment of skin and mucous membrane wounds and in cosmetic applications Pending 23-Sep-2024
US-20260083817-A1 Peptide compositions and their use for the treatment of skin and mucous membrane wounds and in cosmetic applications Pending 23-Sep-2024
AU-2025229739-A1 Controlled-release formulations of glp-1 receptor agonists utilizing self-assembling peptides (saps) Pending 28-Feb-2024
WO-2025184112-A1 Controlled-release formulations of glp-1 receptor agonists utilizing self-assembling peptides (saps) Pending 28-Feb-2024
JP-2025113084-A Intestinal disease mucosal healing agent for subcutaneous administration Pending 22-Jan-2024
To view 3-D Matrix’s complete patent history, request access »

3-D Matrix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

3-D Matrix Investments & Acquisitions (2)

3-D Matrix’s most recent deal was a Merger/Acquisition with 3-D Matrix (Boston, Massachusetts).

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
3-D Matrix (Boston, Massachusetts) Merger/Acquisition Drug Discovery
PURMX Therapeutics Seed Round Drug Discovery
To view 3-D Matrix’s complete investments and acquisitions history, request access »

3-D Matrix ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view 3-D Matrix’s complete esg history, request access »

3-D Matrix Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
3-D Matrix EMEA Hoofddorp, Netherlands 2015

3-D Matrix FAQs

  • When was 3-D Matrix founded?

    3-D Matrix was founded in 2004.

  • Where is 3-D Matrix headquartered?

    3-D Matrix is headquartered in Tokyo, Japan.

  • What is the size of 3-D Matrix?

    3-D Matrix has 129 total employees.

  • What industry is 3-D Matrix in?

    3-D Matrix’s primary industry is Biotechnology.

  • Is 3-D Matrix a private or public company?

    3-D Matrix is a Public company.

  • What is 3-D Matrix’s stock symbol?

    The ticker symbol for 3-D Matrix is 7777.

  • What is the current stock price of 3-D Matrix?

    As of 17-Nov-2026 the stock price of 3-D Matrix is $1.89.

  • What is the current market cap of 3-D Matrix?

    The current market capitalization of 3-D Matrix is $241M.

  • What is 3-D Matrix’s current revenue?

    The trailing twelve month revenue for 3-D Matrix is $76.5M.

  • What is 3-D Matrix’s annual earnings per share (EPS)?

    3-D Matrix’s EPS for 12 months was $0.20.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process